145 related articles for article (PubMed ID: 34778935)
1. Investigating the in vitro steatotic mixture effects of similarly and dissimilarly acting test compounds using an adverse outcome pathway-based approach.
Alarcan J; de Sousa G; Katsanou ES; Spyropoulou A; Batakis P; Machera K; Rahmani R; Lampen A; Braeuning A; Lichtenstein D
Arch Toxicol; 2022 Jan; 96(1):211-229. PubMed ID: 34778935
[TBL] [Abstract][Full Text] [Related]
2. An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitro.
Lichtenstein D; Luckert C; Alarcan J; de Sousa G; Gioutlakis M; Katsanou ES; Konstantinidou P; Machera K; Milani ES; Peijnenburg A; Rahmani R; Rijkers D; Spyropoulou A; Stamou M; Stoopen G; Sturla SJ; Wollscheid B; Zucchini-Pascal N; Braeuning A; Lampen A
Food Chem Toxicol; 2020 May; 139():111283. PubMed ID: 32201337
[TBL] [Abstract][Full Text] [Related]
3. More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells.
Lasch A; Marx-Stoelting P; Braeuning A; Lichtenstein D
Arch Toxicol; 2021 Apr; 95(4):1397-1411. PubMed ID: 33575850
[TBL] [Abstract][Full Text] [Related]
4. Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole.
Luckert C; Braeuning A; de Sousa G; Durinck S; Katsanou ES; Konstantinidou P; Machera K; Milani ES; Peijnenburg AACM; Rahmani R; Rajkovic A; Rijkers D; Spyropoulou A; Stamou M; Stoopen G; Sturla S; Wollscheid B; Zucchini-Pascal N; Lampen A
Chem Res Toxicol; 2018 Aug; 31(8):784-798. PubMed ID: 29995386
[TBL] [Abstract][Full Text] [Related]
5. Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines.
Knebel C; Buhrke T; Süssmuth R; Lampen A; Marx-Stoelting P; Braeuning A
Arch Toxicol; 2019 May; 93(5):1311-1322. PubMed ID: 30989312
[TBL] [Abstract][Full Text] [Related]
6. An eight-compound mixture but not corresponding concentrations of individual chemicals induces triglyceride accumulation in human liver cells.
Lichtenstein D; Lasch A; Alarcan J; Mentz A; Kalinowski J; Schmidt FF; Pötz O; Marx-Stoelting P; Braeuning A
Toxicology; 2021 Jul; 459():152857. PubMed ID: 34273450
[TBL] [Abstract][Full Text] [Related]
7. Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis.
Tolosa L; Gómez-Lechón MJ; Jiménez N; Hervás D; Jover R; Donato MT
Toxicol Appl Pharmacol; 2016 Jul; 302():1-9. PubMed ID: 27089845
[TBL] [Abstract][Full Text] [Related]
8. Integrate mechanistic evidence from new approach methodologies (NAMs) into a read-across assessment to characterise trends in shared mode of action.
Escher SE; Aguayo-Orozco A; Benfenati E; Bitsch A; Braunbeck T; Brotzmann K; Bois F; van der Burg B; Castel J; Exner T; Gadaleta D; Gardner I; Goldmann D; Hatley O; Golbamaki N; Graepel R; Jennings P; Limonciel A; Long A; Maclennan R; Mombelli E; Norinder U; Jain S; Capinha LS; Taboureau OT; Tolosa L; Vrijenhoek NG; van Vugt-Lussenburg BMA; Walker P; van de Water B; Wehr M; White A; Zdrazil B; Fisher C
Toxicol In Vitro; 2022 Mar; 79():105269. PubMed ID: 34757180
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.
Chen-Liaw AY; Hammel G; Gomez G
In Vitro Cell Dev Biol Anim; 2017 Sep; 53(8):721-727. PubMed ID: 28707223
[TBL] [Abstract][Full Text] [Related]
10. Combinations of LXR and RXR agonists induce triglyceride accumulation in human HepaRG cells in a synergistic manner.
Lasch A; Alarcan J; Lampen A; Braeuning A; Lichtenstein D
Arch Toxicol; 2020 Apr; 94(4):1303-1320. PubMed ID: 32123961
[TBL] [Abstract][Full Text] [Related]
11. Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis.
Angrish MM; McQueen CA; Cohen-Hubal E; Bruno M; Ge Y; Chorley BN
Toxicol Sci; 2017 Sep; 159(1):159-169. PubMed ID: 28903485
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Drug Metabolism by the Interplay of Inflammatory Signaling, Steatosis, and Xeno-Sensing Receptors in HepaRG Cells.
Tanner N; Kubik L; Luckert C; Thomas M; Hofmann U; Zanger UM; Böhmert L; Lampen A; Braeuning A
Drug Metab Dispos; 2018 Apr; 46(4):326-335. PubMed ID: 29330220
[TBL] [Abstract][Full Text] [Related]
13. Adverse outcome pathway-based analysis of liver steatosis in vitro using human liver cell lines.
Karaca M; Fritsche K; Lichtenstein D; Vural Ö; Kreuzer K; Alarcan J; Braeuning A; Marx-Stoelting P; Tralau T
STAR Protoc; 2023 Sep; 4(3):102500. PubMed ID: 37616165
[TBL] [Abstract][Full Text] [Related]
14. Transcript and protein marker patterns for the identification of steatotic compounds in human HepaRG cells.
Lichtenstein D; Mentz A; Schmidt FF; Luckert C; Buhrke T; Marx-Stoelting P; Kalinowski J; Albaum SP; Joos TO; Poetz O; Braeuning A
Food Chem Toxicol; 2020 Nov; 145():111690. PubMed ID: 32810590
[TBL] [Abstract][Full Text] [Related]
15. Estimation of toxicity of chemical mixtures through modeling of chemical interactions.
Mumtaz MM; De Rosa CT; Groten J; Feron VJ; Hansen H; Durkin PR
Environ Health Perspect; 1998 Dec; 106 Suppl 6(Suppl 6):1353-60. PubMed ID: 9860892
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
[TBL] [Abstract][Full Text] [Related]
17. An adverse outcome pathway based in vitro characterization of novel flame retardants-induced hepatic steatosis.
Negi CK; Bajard L; Kohoutek J; Blaha L
Environ Pollut; 2021 Nov; 289():117855. PubMed ID: 34340181
[TBL] [Abstract][Full Text] [Related]
18. Selecting mixtures on the basis of dietary exposure and hazard data: application to pesticide exposure in the European population in relation to steatosis.
Crépet A; Vanacker M; Sprong C; de Boer W; Blaznik U; Kennedy M; Anagnostopoulos C; Christodoulou DL; Ruprich J; Rehurkova I; Domingo JL; Hamborg Jensen B; Metruccio F; Moretto A; Jacxsens L; Spanoghe P; Senaeve D; van der Voet H; van Klaveren J
Int J Hyg Environ Health; 2019 Mar; 222(2):291-306. PubMed ID: 30579770
[TBL] [Abstract][Full Text] [Related]
19. Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells.
Anthérieu S; Rogue A; Fromenty B; Guillouzo A; Robin MA
Hepatology; 2011 Jun; 53(6):1895-905. PubMed ID: 21391224
[TBL] [Abstract][Full Text] [Related]
20. A human hepatocellular in vitro model to investigate steatosis.
Gómez-Lechón MJ; Donato MT; Martínez-Romero A; Jiménez N; Castell JV; O'Connor JE
Chem Biol Interact; 2007 Jan; 165(2):106-16. PubMed ID: 17188672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
